(877) 505-4777| info@speakersnetwork.com

Genetics & Personalized Medicine

Assistant Professor, Division of Population Sciences
Clinical Cancer Genetics Department
City of Hope National Cancer Center

Hereditary Cancer and Related Issues: Ethical, Legal, Psychosocial, etc.
Role of RN / MD
Genetic Counseling for Inherited Cancer Risk
Management of Hereditary Breast Cancer or Colon Cancer
Risk Assessment for Hereditary Cancer

Director, Translational Medicine
F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute
Joshua L. and Lisa Z. Greer Chair in Inflammatory Bowel Disease Genetics
Professor of Medicine,
Division of Gastroenterology
Cedars-Sinai Medical Center

Inflammatory Bowel Disease
Ulcerative Colitis: Therapeutics, Pathophysiology, Genetics
Crohns Disease: Therapeutics, Pathophysiology, Genetics
Celiac Diease


Chief, Division of Clinical Cancer Genetics
Professor of Oncology and Population Sciences
City of Hope National Medical Center

Genetic Cancer Risk Assessment: Who Should Be Tested?
Hereditary Cancers: Identification and Assessment of High Risk Families
Genetic Cancer Risk Assessment in Underserved Populations.
Influence of Culture on health behavior in a High Risk Hispanic Cohort
If We Build It…Will They Come? – Establishing a Cancer Genetics Services Clinic for an Underserved Predominantly Latina Cohort.
Power of Partnership: Extending Comprehensive Cancer Center Expertise in Clinical Cancer Genetics to Community Breast Care Centers
Challenges in Genetic Testing Interpretation

Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzels multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors.
The presentation was excellent and he is really great about presenting in a way that is totally understandable and is evidence based. – Las Palmas Medical Center

Director, Cancer Genetics Education Program
Clinical Assistant Professor
Division of Clinical Cancer Genetics
City of Hope Comprehensive Cancer Center

Documenting the Family Health History: A primer for healthcare professionals

Documenting the Family History of Cancer: What you and your patients need to know

Basic Genetics/Genomics: A primer for healthcare providers

The Basic Science of Cancer Genetics

Genetic Cancer Risk Counseling Strategies

Genetic Cancer Risk Assessment: Who Should Be Tested?

Breast Cancer Risk Assessment

Outsmarting Cancer: Is Genetic Testing for Your Patient?

Promoting Cancer Prevention through Genetic/Genomic Cancer Risk Assessment

Personalized Medicine in the Genomic Era: What You and Your Patients Need to Know

Genetic Cancer Risk Assessment and Your Practice: Personalized Medicine in the Genomics Era

Hereditary Cancer Predisposition in Jewish Populations

Identifying and Managing Hereditary Breast and Ovarian Cancer Patients

Identifying and Managing Hereditary Gastrointestinal Cancer Syndromes

Breast, Ovarian, and Colorectal Cancer: The Benefits and Limitations of Genetic Testing and Risk Management in Clinical Care

Identifying and Managing Patients with Hereditary Endocrine Neoplasias

Pediatric Cancer Syndromes

Genodermatoses: Hereditary Melanoma and Other Cancer Syndromes with Cutaneous Manifestations

Applications and Limitations of Next-Generation Sequence Testing in the Genomics Era

Ethical, Legal, and Social Issues in the Genomics Era

Kathleen R. Blazer, Ed.D. M.S., L.C.G.C. is Clinical Assistant Professor of the City of Hope Department of Populations Sciences, Associate Director of the City of Hope Cancer Genetics Education Program (CGEP), and a bilingual (English/Spanish) licensed, board-certified cancer risk genetic counselor in the City of Hope Division of Clinical Cancer Genetics. She has worked in the development, administration and assessment of the federal grant funded initiatives of the CGEP (a multifaceted cancer genetics education and training initiative for physicians and other health care professionals) since joining the division in 1998. Dr. Blazer has first-authored a number of peer-reviewed publications reporting the development and outcomes of the professional education and training research initiatives conducted by the CGEP. The outcomes and theoretical framework of her doctoral research in distance training for cancer genetics serve as the cornerstone of a Global Clinical Cancer Genetics Community of Practice (CCGCoP) initiative that includes outreach across Latin America. Dr. Blazers clinical responsibilities include providing pro-bono bilingual cancer risk assessment and genetic counseling services to underserved Latino families through a compassionate-funded outreach program established by the Division of Clinical Cancer Genetics. Dr. Blazer is a member of the American Society of Human Genetics, the National Society of Genetic Counselors, the American Association of Cancer Education, and the Advisory Board of the Physicians Data Query of the National Cancer Institute.
We really enjoyed having Elizabeth Blazer present her topic! She was excellent, and the audience was quite engaged in the talk. VERY Good Speaker! – Pomona Valley Medical Center Just to let you know Dr. Blazer was awesome and a lovely person!  The audience really enjoyed her!  You are batting 1000!! – Orange Coast Memorial Medical Center

Director, Molecular Diagnostics
City of Hope Medical Center

Genetic Testing


Assistant Clinical Professor, Department of Medical Oncology, Division of Clinical Cancer Genetics
Program Member, Cancer Control and Population Sciences
City of Hope National Medical Center

Hereditary Cancer Predisposition
Breast and Ovarian Cancer Genetics Ê
Hereditary Cancer Genetics
Genodermatoses in Cancer
Adult Cancer Genetics
Pediatric Cancer Syndromes

Dr. Thomas Slavin, is an Assistant Professor in the Department of Medical Oncology, Division of Clinical Cancer Genetics, as well as, a Cancer Control and Population Sciences Program Member, at City of Hope National Medical Cancer Center. Dr. Slavin graduated with honors with both an undergraduate degree and medical doctorate at the University of South Florida. Following medical school, he completed both a pediatric and a medical genetics residency program at Rainbow Babies and Childrens Hospital/University Hospitals, Case Medical Center in Cleveland, Ohio.Ê In residency, he completed a postdoctoral year of research in genetic epidemiology where he identified novel genetic epidemiologic associations for coronary artery disease and hypertension under Dr. Robert Elston.ÊDr. Slavin is board certified in clinical genetics, molecular diagnostics and pediatrics, and is an accomplished and experienced clinician, clinical researcher and committed teacher. His particular research interests are in preventative and precision cancer genomics, and epidemiology, particularly of hereditary gastrointestinal related malignancies. He has 20 peer-reviewed publications and has presented at numerous national meetings.